BRIEF published on 06/20/2024 at 11:02, 3 months 17 days ago Hoffmann Green Cement signs a strategic partnership with Polylogis and LogiOuest Sustainable Construction Partnership Hoffmann Green Cement Polylogis LogiOuest
BRIEF published on 06/17/2024 at 08:05, 3 months 21 days ago World first: a wind turbine foundation made of 0% clinker carbon-free concrete Innovation Renewable Energies Ecological Transition Wind Turbine Carbon-free Concrete
Published on 10/07/2024 at 23:00, 9 hours 49 minutes ago Cerrado Gold Appoints Andrew Croal as Chief Technical Officer
Published on 10/07/2024 at 23:00, 9 hours 49 minutes ago Condor Resources Terminates Option Agreement on Soledad Project
Published on 10/07/2024 at 22:30, 10 hours 19 minutes ago Braille Energy Systems Inc. Provides Update on EARLYALERT Lithium Battery Warning System
Published on 10/08/2024 at 08:32, 17 minutes ago Blue Cap AG: Successful sale of Neschen Coating GmbH above net asset value valuation
Published on 10/08/2024 at 08:00, 49 minutes ago Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Published on 10/08/2024 at 08:00, 49 minutes ago Dalata Hotel Group PLC: POS-Transaction in Own Shares
Published on 10/08/2024 at 07:45, 1 hour 4 minutes ago Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Published on 10/08/2024 at 07:30, 1 hour 19 minutes ago Nordex Group receives orders totalling 500 MW from Canada
Published on 10/08/2024 at 08:30, 19 minutes ago Edenred invests in the Shift4Good fund to support the emergence of smarter, more responsible mobility
Published on 10/08/2024 at 08:30, 19 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 30/09/2024 to 04/10/2024
Published on 10/08/2024 at 08:07, 41 minutes ago Reporting on share buyback transactions carried out between October 1 and October 4, 2024
Published on 10/08/2024 at 08:00, 49 minutes ago MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)
Published on 10/08/2024 at 08:00, 49 minutes ago NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.